D-Index & Metrics Best Publications
Neuroscience
Sweden
2022

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Neuroscience D-index 90 Citations 24,773 307 World Ranking 397 National Ranking 10
Medicine D-index 100 Citations 34,271 413 World Ranking 3707 National Ranking 75

Research.com Recognitions

Awards & Achievements

2022 - Research.com Neuroscience in Sweden Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Dopamine
  • Pharmacology

Lars Farde mainly investigates Internal medicine, Endocrinology, Dopamine receptor, Raclopride and Receptor. His Healthy subjects research extends to the thematically linked field of Endocrinology. The study incorporates disciplines such as Haloperidol and Pharmacology in addition to Dopamine receptor.

The Raclopride study combines topics in areas such as Basal ganglia, Dopamine antagonist, Ketanserin and Receptor antagonist. Lars Farde is interested in Radioligand, which is a branch of Receptor. His research on Radioligand also deals with topics like

  • Pathology, which have a strong connection to Molecular biology and Positron emission tomography,
  • Binding potential together with Antagonist and Transient equilibrium.

His most cited work include:

  • Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine: Relation to Extrapyramidal Side Effects (1229 citations)
  • Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. (768 citations)
  • Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic Drugs (607 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Radioligand, Internal medicine, Endocrinology, Pharmacology and Receptor. His work deals with themes such as Positron emission tomography, Binding potential, Nuclear medicine and Human brain, which intersect with Radioligand. His Positron emission tomography research incorporates themes from Nuclear magnetic resonance and Pathology.

He has researched Internal medicine in several fields, including Neocortex and Oncology. His Endocrinology and Raclopride, Dopamine receptor, Dopamine, Striatum and Putamen investigations all form part of his Endocrinology research activities. His Pharmacology research also works with subjects such as

  • Psychosis most often made with reference to Antipsychotic,
  • Clozapine which is related to area like Atypical antipsychotic.

He most often published in these fields:

  • Radioligand (45.91%)
  • Internal medicine (37.19%)
  • Endocrinology (32.03%)

What were the highlights of his more recent work (between 2014-2021)?

  • Radioligand (45.91%)
  • Positron emission tomography (30.60%)
  • Internal medicine (37.19%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Radioligand, Positron emission tomography, Internal medicine, Pharmacology and Binding potential. His research in Radioligand intersects with topics in Metabotropic glutamate receptor 5, Healthy control, Ventral striatum and Pathology. His Internal medicine research includes elements of Endocrinology, Neurology, Oncology and Temporal cortex.

The concepts of his Endocrinology study are interwoven with issues in Apolipoprotein E and Parenchyma. Lars Farde combines subjects such as Receptor, Brain tumor, In vivo and Afatinib with his study of Pharmacology. He interconnects Striatum, Raclopride, Dopamine transporter, Human brain and Nuclear magnetic resonance in the investigation of issues within Binding potential.

Between 2014 and 2021, his most popular works were:

  • Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease. (106 citations)
  • Test-retest reproducibility of [(11)C]PBR28 binding to TSPO in healthy control subjects. (87 citations)
  • Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [ 11 C]PBR28 (69 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Dopamine
  • Enzyme

His scientific interests lie mostly in Internal medicine, Translocator protein, Radioligand, Neuroscience and Endocrinology. His work in the fields of Internal medicine, such as Body mass index, intersects with other areas such as Cell marker. His Radioligand research incorporates elements of Reliability, Glial activation, Test retest reproducibility and Reproducibility.

Neuroscience is represented through his Dopamine and Positron emission tomography research. The Dopamine study which covers Pet imaging that intersects with Neurotransmitter. His studies in Endocrinology integrate themes in fields like Microglia, In vivo and Serotonin.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine: Relation to Extrapyramidal Side Effects

Lars Farde;Anna-Lena Nordström;Frits-Axel Wiesel;Stefan Pauli.
Archives of General Psychiatry (1992)

1944 Citations

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

Lars Farde;Hakan Hall;Erling Ehrin;Goran Sedvall.
Science (1986)

994 Citations

Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic Drugs

Lars Farde;Fritz-Axel Wiesel;Christer Halldin;Göran Sedvall.
Archives of General Psychiatry (1988)

826 Citations

Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.

E G Jönsson;M M Nöthen;F Grünhage;L Farde.
Molecular Psychiatry (1999)

754 Citations

The correlative triad among aging, dopamine, and cognition: current status and future prospects.

Lars Bäckman;Lars Nyberg;Ulman Lindenberger;Shu-Chen Li.
Neuroscience & Biobehavioral Reviews (2006)

746 Citations

Changes in Cortical Dopamine D1 Receptor Binding Associated with Cognitive Training

F McNab;A Varrone;L Farde;A Jucaite.
Science (2009)

680 Citations

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.

Lars Farde;Frits-Axel Wiesel;Sharon Stone-Elander;Christer Halldin.
Archives of General Psychiatry (1990)

664 Citations

Age-related cognitive deficits mediated by changes in the striatal dopamine system.

Lars Bäckman;Nathalie Ginovart;Roger A. Dixon;Tarja-Brita Robins Wahlin.
American Journal of Psychiatry (2000)

619 Citations

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients

Anna-Lena Nordström;Lars Farde;Frits-Axel Wiesel;Kaj Forslund.
Biological Psychiatry (1993)

607 Citations

Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis.

L. Farde;L. Eriksson;G. Blomquist;C. Halldin.
Journal of Cerebral Blood Flow and Metabolism (1989)

505 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Lars Farde

Christer Halldin

Christer Halldin

Stockholm County Council

Publications: 249

Shitij Kapur

Shitij Kapur

King's College London

Publications: 149

Tetsuya Suhara

Tetsuya Suhara

National Institutes for Quantum and Radiological Science and Technology

Publications: 134

Nora D. Volkow

Nora D. Volkow

National Institute on Drug Abuse

Publications: 120

Alan A. Wilson

Alan A. Wilson

Centre for Addiction and Mental Health

Publications: 115

Roger N. Gunn

Roger N. Gunn

Imperial College London

Publications: 96

Robert B. Innis

Robert B. Innis

National Institutes of Health

Publications: 92

Marc Laruelle

Marc Laruelle

Columbia University

Publications: 89

Joanna S. Fowler

Joanna S. Fowler

Brookhaven National Laboratory

Publications: 86

Gary Remington

Gary Remington

Centre for Addiction and Mental Health

Publications: 86

Ulman Lindenberger

Ulman Lindenberger

Max Planck Society

Publications: 83

Oliver D. Howes

Oliver D. Howes

King's College London

Publications: 82

Anissa Abi-Dargham

Anissa Abi-Dargham

Columbia University

Publications: 78

Bengt Långström

Bengt Långström

Uppsala University

Publications: 77

Victor W. Pike

Victor W. Pike

National Institutes of Health

Publications: 76

Lars Bäckman

Lars Bäckman

Karolinska Institute

Publications: 75

Trending Scientists

Ross T. Whitaker

Ross T. Whitaker

University of Utah

Jose Maria Gil

Jose Maria Gil

Universitat Politècnica de Catalunya

Zhang-Cheng Hao

Zhang-Cheng Hao

Southeast University

Shinya Sugiura

Shinya Sugiura

University of Tokyo

Daichao Sheng

Daichao Sheng

University of Technology Sydney

Michael J. Natan

Michael J. Natan

Pennsylvania State University

Kaibin Tang

Kaibin Tang

University of Science and Technology of China

Derek J. Fray

Derek J. Fray

University of Cambridge

Chai Jaturapitakkul

Chai Jaturapitakkul

King Mongkut's University of Technology Thonburi

Muthukaruppan Alagar

Muthukaruppan Alagar

Vignan's Foundation for Science, Technology & Research

Wn Konings

Wn Konings

University of Groningen

Alan J. Barrett

Alan J. Barrett

Wellcome Sanger Institute

Toshimasa Ohara

Toshimasa Ohara

National Institute for Environmental Studies

Noreen M. Webb

Noreen M. Webb

University of California, Los Angeles

Masahito Ueda

Masahito Ueda

University of Tokyo

Something went wrong. Please try again later.